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hospital stay was higher in HOSP2 (11.3 vs. 14.5, p < 0.01). Sig-
niﬁcant differences were anyway conﬁrmed only among non
infected patients. Our results were not conﬁrmed with the boot-
strap method. CONCLUSIONS: Cost of antibiotic therapy, its
effects on the risk of infections and length of remission can be
inﬂuenced by the therapeutic choices. Information on potential
consequences is useful to implement optimal therapeutic
approaches.
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OBJECTIVES: The aim of this study to calculate the health
insurance cost of treatment of patients with peritrochanter frac-
ture of femur from the ﬁrst hospital admission for 18 months
follow up period according to most frequently used 4 different
surgical methods (ender nailing, ﬁx angled plate, gamma nailing
and dynamic hip screw ﬁxation (DHS). METHODS: Recruit-
ment criteria were: 1) all patients with a hip fracture in 2000
deﬁned by the International Classiﬁcation of Disease (ICD) as
“S7210”; 2)working age between 18–65; 3) ﬁrst admission to
surgical unit, and had an operation because of monotraumatic
peritrochanteric fracture of femur; and 4) without comorbidities.
The cost analysis includes the cost of acute and chronic in-patient
care, outpatient care and sick pay. RESULTS: The total number
of patients having peritrochanteric fracture of the femur was
1154. Due to the inclusion criteria listed in the data and methods
chapter altogether 186 patients were included into the study. The
total costs were the highest in case of those types of operations
with lower cost of prosthesis device and lower load stability:
Ender nailing €2322, ﬁx angled plate €2109 because of the
higher sick-pay costs. The total costs were the lowest in case of
those types of operations with higher cost of prosthesis device
and higher load stability (Gamma nailing €2022, dynamic hip
screw €1836) because of the lower sick-pay costs. The average
days spent on sickness-pay varied according to the types of sur-
gical methods. Gamma nailing-182 days, DHS ﬁxation-212
days, Ender nailing—310 days, ﬁx angled plate—269 days.
CONCLUSION: In case of surgical methods with lower com-
plication rate and quicker load stability (Gamma nailing, DHS
ﬁxation) the cost of primary treatment is higher but the total
costs are lower because of lower additional costs (chronic care,
sickness-pay).
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OBJECTIVE: The purpose of this study was to analyze blood
transfusion patterns and associated costs by various spinal
surgery subtypes in the US inpatient setting. METHODS: This
study used Premier’s US Inpatient Comparative Database, con-
taining approximately 5 million admissions annually, from over
500 hospitals. A total of 31,808 inpatient discharges with
primary procedure codes for spinal fusion surgery (ICD-9 codes
81.01–81.08, 81.31–81.38, 81.61; US projected total: 274,523)
between July 2003 and June 2004 were selected and stratiﬁed
into seven surgical subtypes based on the anatomic location of
fused vertebrae and surgical technique. Blood management pat-
terns were examined pre- and post-surgery. The association
between spinal surgery subtypes and blood transfusion costs
were examined using multivariate regression after controlling for
various patient-(age, race, gender, severity), hospital-(location,
teaching status, bedsize, region), and clinical-factors, inpatient
mortality, payer type (Medicare, Medicaid, commercial/managed
care), and physician specialty. RESULTS: Spinal fusion surgeries
incurred average (maximum) blood transfusion costs of
$149–$493 ($3,300–$13,120) per surgery, depending on
subtype. As compared to cervical fusions, dorsal/dorsolumbar
and lumbar/lumbosacral fusions as well as refusions were 
associated with signiﬁcantly higher blood transfusion costs
($100–$195; p < 0.0001). Being operated by a neurosurgeon was
associated with lower blood transfusion costs (p < 0.0001).
Blood transfusion costs increased with increasing patient sever-
ity ($967), hospital bedsize ($100–$142), and urban/teaching
status (p < 0.0001). Use of volume expanders and erythropoetic
agents signiﬁcantly increased blood transfusion costs by $184
and $294, respectively (p < 0.0001). Being male, discharged to
home, and the use of topical sealants, were associated with lower
total transfusion costs. CONCLUSIONS: This study demon-
strates that the anatomical location, surgical approach, physician
specialty, and hospital characteristics are all associated with
blood transfusion costs. Newer technologies/medications may
reduce blood transfusion use/costs, and this potential for reduc-
tion may be even greater in certain subgroups.
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OBJECTIVE: To analyze blood transfusion patterns and associ-
ated costs in hip/knee replacement and revision surgeries in the
US inpatient setting. METHODS: This study used Premier’s US
Inpatient Comparative Database, containing approximately 5
million discharges annually, from over 500 hospitals. A total of
12,211 inpatient discharges with a primary procedure for hip
(ICD-9 codes 81.51, 81.53; US projected total: 274,542 proce-
dures) and 17,805 for knee arthroplasty (ICD-9 codes 81.54,
81.55; US projected total: 494,629 procedures) between July
2003 and June 2004 were evaluated. Blood management pat-
terns were examined pre- and post-surgery. The association
between surgery subtypes and transfusion costs were examined
using multivariate regression after controlling for various
patient-(age, race, gender, severity), hospital-(location, teaching
status, bedsize, region), and clinical-factors, inpatient mortality,
payer type (Medicare, Medicaid, commercial/managed care), and
physician specialty. RESULTS: Average (maximum) blood trans-
fusion costs of $448 ($11,838), $720 ($27,957), $321
($17,328), and $427 ($5182) were incurred for total hip replace-
ment, hip revision, knee replacement, and knee revision, respec-
tively. Multivariate analyses showed that hip and knee revision
costs were $272 and $66 higher than hip replacement, respec-
tively (p < 0.0001). Being operated on by an orthopedic surgeon
was associated with slightly lower total transfusion costs (p <
0.0001). Blood transfusion costs increased with increasing sever-
ity ($1049; p < 0.001), comparing most severe to mild. Use of
hypotensive anesthesia and topical sealants were associated with
a $131 and $101 reduction, respectively, whereas the use of ery-
thropoetic agents was associated with a $210 increase in total
transfusion costs (p < 0.0001). Blood transfusion costs increased
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with bedsize, and showed variations by region. CONCLU-
SIONS: This study demonstrates that orthopedic surgery type,
physician specialty, patient severity, hospital characteristics, and
use of pharmacological agents impact total blood transfusion
costs. Newer medications/technologies may reduce blood trans-
fusion costs in hip/knee surgeries, and this reduction may be even
greater in certain subgroups.
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OBJECTIVES: The actual extent of health technologies utiliza-
tion is fundamental criterion for health technology assessment
and management. Although crucial, this information may not be
accurately available due to incomplete clinical registries and
other limitations. As this is a major hindrance we developed a
model enabling indirect assessment of the technology utilization,
by measuring techno-markers, which are speciﬁcally associated
with the technology under study. METHODS: During 2004 we
evaluated the model by collecting data on techno-markers for
cardiac surgery in one Israeli medical center. The Techno-
markers chosen were compared to surgical registries and esti-
mate error was calculated. Estimate error less than 5% indicates
non-signiﬁcant differences between techno-markers and surgical
registries. RESULTS: Total of 1040 cardiac surgeries was com-
pared to utilization of 1064 (2.3%) surgical-drapes and 1224
(17.7%) bone-wax units. In addition, 832 cardiopulmonary
bypass (CPB) surgeries were compared to utilization of 874 (5%)
oxygenators, 854 (2.6%) cardioplegia-sets, 1029 (23.7%)
control-valves, and 848 (1.9%) aortic-cannulas. Furthermore,
utilization of 208 “off-pump” coronary artery bypass (OPCAB)
were compared to 204 (2%) air-water blowers, and 241 (15.8%)
stabilizers CONCLUSIONS: Techno-markers demonstrated an
estimate error less than 5% (surgical-drapes for cardiac surg-
eries, oxigenators, cardioplegia-sets, and aortic-cannulas for
CPB, and air-water blowers for OPCAB) require further statisti-
cal analysis for establishing a comprehensive utilization model.
Signiﬁcant differences between observed and expected should
alert the management system. In conclusion, valuable techno-
markers must be distinctive to the technology and easy to
monitor, thus their selection requires good clinical understand-
ing of the technology. When chosen appropriately, techno-
markers can provide a new approach for estimating and super-
vising the extent of health technology utilization.
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BACKGROUND: Patient Reported Outcomes (PRO) and par-
ticularly Patient Satisfaction (PS) are nowadays important mea-
sures of the overall quality of health care. ISO 9001:2001
requires regularly performed, patient surveys as quality moni-
toring tools. OBJECTIVES: To monitor the quality of health care
provided by a cardiosurgical unit in Poland using PS evaluation
and to apply the results to its administration. METHODS: A 48-
item questionnaire was designed that deﬁnes nine areas of
medical care (reception, sanitation, stuff, rehabilitation, medical
care, food & diet, patient rights, hospital, suggestions). In 45
scaled questions a ﬁve-point Likert scale (very poor, poor, barely
acceptable, good, very good) was used. There were 3 open-ended
questions. A survey of 150 patients was conducted in 2004. All
patients, who underwent cardiosurgical procedures were
included during their 7-days post-operative stay in the intensive
care unit. For the analysis, all questions were categorized into 
3 dimensions: technical, functional and environmental (A. 
Donabedian, 1980). RESULTS: A total of 128 questionnaires
(87.5%) were returned of which 94 (73.5%) were from males.
The majority (96.7%) were treated for the ﬁrst time. Less then
1% were younger than 41 years, 52.8% were between 41 and
60 years. The majority 97.7% of answers were positive. Areas
with relatively high share of negative assessment were identiﬁed
as rehabilitation (4.6%), food & diet (5.0%) and patient rights
(7.0%). Qualitative analyzes of food & diet area, illustrated
main complains: 52.2% eating hours, 13% taste, 8.7% diet
needs. Additionally, functional and environmental dimensions
were evaluated more positively then technical dimension. CON-
CLUSION: Patients overall presented a high level of reported
satisfaction on aspects of their care relating to function and envi-
ronment, and a lower level of satisfaction in technical aspects of
care. This study demonstrates a practical application of PRO
surveys in monitoring the quality of health care unit. The results
could be applied in enhancing local unit management and
improving the efﬁcient distribution of resources.
